Patients With CLL Present Heterogeneously
Certain patients may present asymptomatically, affecting treatment options.
Source: pharmacytimes.com
Page 11 - Practice Guidelines News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Practice Guidelines. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Practice Guidelines Today - Breaking & Trending Today
AstraZeneca's Tagrisso plus chemotherapy appoved for lung cancer in the US
AstraZeneca's Tagrisso approved in the US for EGFRm non-small cell lung cancer with chemotherapy. FLAURA2 trial results show significant benefit.
Source: directorstalkinterviews.com
A Review of Anti-HER2 Targeted Agents in Non-Breast Solid Tumors
This review summarizes current utilization of anti-HER2 targeted therapy across several non-breast solid tumors in the setting of advanced disease.
Source: pharmacytimes.com
Probe Gold Announces Updated PEA for Novador Project,
Highlights: Robust economics: pre-tax net present value (“NPV”) of C$1.53 billion, post-tax NPV of C$910 million, pre-tax internal rate of...
Source: globenewswire.com
Advancing Treatment Selection in CLL Management
Treatment options are distinct in their mechanisms, safety profiles, and implications for patients’ quality of life.
Source: pharmacytimes.com